BridgeMD
New treatment option for Anorexia Nervosa
Official title Efficiency of Virtual Reality Exposure Therapy in the Management of Body Dysmorphic Disorders in Female Adolescents With Anorexia Nervosa
ClinicalTrials.gov ID: NCT04107870
What this study is testing
- What it's testing
- Anorexia nervosa is defined in DSM V as a quantitative and qualitative dietary restriction resulting in significant weight loss, intense fear of weight gain, altered weight and body shape perception (body dysmorphic disorder) and low self-esteem influenced by weight or body shape. Body dysmorphic disorder is the most difficult symptom to manage in anorexia nervosa and its persistence is a factor associated with relapse.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 13 to 17, women only
You may be able to join if
- Female adolescents aged 13 to 18
- with a diagnosis of anorexia nervosa of all types (including purgative and hyperphagic) according to the DSM-V
- French as first language
- agreed to participate in the study
- parental authority holders accepting her participation in the study
See the full eligibility criteria
- Female adolescents aged 13 to 18
- with a diagnosis of anorexia nervosa of all types (including purgative and hyperphagic) according to the DSM-V
- French as first language
- agreed to participate in the study
- parental authority holders accepting her participation in the study
- affiliated to a social security system Patients will not be included in the study:
- with a somatic severity criterion:
- Total aphagia
- Body mass index (BMI) \< 14kg/m² for those over 17 years of age, BMI \< 13.2kg/m² for those aged 15-16 and BMI \< 12.7kg/m² for those aged 13-14.
- Confusion
- Bradycardia \<40/min, Tachycardia
- Blood pressure \< 80/50mmHg
- Hypothermia \<35.5°C
- Severe metabolic disorders: hypokalemia \ 150 mmol/l, hypophosphoremia \< 0.5 mmol/l
- Acetonuria, hypoglycemia \< 0.6g/l
- Creatinine elevation \> 100micromol/l
- Cytolysis \> 4N
- Leuconeutropenia \<1000/mm3
- Thrombocytopenia \<6000000/mm3
- Suicide attempt in the last month before inclusion
- Receiving benzodiazepine treatment outside the prescription limits.
- Psychotic patients or patients with psychoactive substance addiction according to MINI KID criteria (Sheehan DV et al. Reliability and validity of the Mini International Neuropsychiatric Interview for children and...
The study team makes the final eligibility decision.
Where it's taking place
- Reims, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 13 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Reims, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.